Abstract
Cdc25 phosphatases act on cell cycle checkpoints. Several kinds of tumors overexpress this enzyme.Therefore, the study of Cdc25s inhibitors can aid the development of new anticancer therapies. Several low specificity inhibitors have been already described for Cdc25B, isoform which crystal structure of the catalytic domain has been determined by X-ray diffraction. Computational data indica…